» Articles » PMID: 18087291

The DNA Damage Response Pathways: at the Crossroad of Protein Modifications

Overview
Journal Cell Res
Specialty Cell Biology
Date 2007 Dec 19
PMID 18087291
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Post-translational modifications play a crucial role in coordinating cellular response to DNA damage. Recent evidence suggests an interplay between multiple protein modifications, including phosphorylation, ubiquitylation, acetylation and sumoylation, that combine to propagate the DNA damage signal to elicit cell cycle arrest, DNA repair, apoptosis and senescence. Utility of specific post-translational modifiers allows temporal and spatial control over protein relocalization and interactions, and may represent a means for trans-regulatory activation of protein activities. The ability to recognize these specific modifiers also underscores the capacity for signal amplification, a crucial step for the maintenance of genomic stability and tumor prevention. Here we have summarized recent findings that highlight the complexity of post-translational modifications in coordinating the DNA damage response, with emphasis on the DNA damage signaling cascade.

Citing Articles

An Efficient Synthesis of Novel Aminothiazolylacetamido-Substituted 3,5-Bis(arylidene)-4-piperidone Derivatives and Their Cytotoxicity Studies.

Suresh T, Nachiappan D, Karthikeyan G, Vijayakumar V, Jasinski J, Sarveswari S ACS Omega. 2024; 9(27):29244-29251.

PMID: 39005779 PMC: 11238287. DOI: 10.1021/acsomega.4c00039.


Deciphering the molecular landscape of ionising radiation-induced eye damage with the help of genomic data mining.

Baralic K, Bozovic P, dukic-Cosic D Arh Hig Rada Toksikol. 2024; 75(2):91-101.

PMID: 38963141 PMC: 11223508. DOI: 10.2478/aiht-2024-75-3817.


YTHDC1 mA-dependent and mA-independent functions converge to preserve the DNA damage response.

Elvira-Blazquez D, Fernandez-Justel J, Arcas A, Statello L, Goni E, Gonzalez J EMBO J. 2024; 43(16):3494-3522.

PMID: 38951610 PMC: 11329685. DOI: 10.1038/s44318-024-00153-x.


Lectins as a promising therapeutic agent for breast cancer: A review.

Singh K, Agrawal L, Gupta R, Singh D, Kathpalia M, Kaur N Breast Dis. 2024; 43(1):193-211.

PMID: 38905027 PMC: 11307042. DOI: 10.3233/BD-230047.


Navigating therapeutic strategies: HPV classification in head and neck cancer.

Tabatabaeian H, Bai Y, Huang R, Chaurasia A, Darido C Br J Cancer. 2024; 131(2):220-230.

PMID: 38643337 PMC: 11263586. DOI: 10.1038/s41416-024-02655-1.